Mr Tevita Aho

Tev moved from New Zealand to the UK in 2003 to take up a Fellowship in Uro-oncology at Cambridge University Hospitals NHS Foundation Trust (CUH). He was appointed as a consultant at CUH after completing his fellowship and has specialised in benign prostate and kidney cancer surgery since.

During his training in NZ he spent a year learning Holmium Laser Enucleation of the Prostate (HoLEP) from the urologists who invented it (Peter Gilling & Mark Fraundorfer).

In 2004, Tev introduced HoLEP at CUH where it rapidly became, and remains, the gold standard surgical treatment for male Lower Urinary Tract Symptoms and urinary retention. CUH was one of the first UK centres to offer HoLEP.

Tev is the most experienced HoLEP surgeon in the UK (has done more than 2,200 procedures). He is frequently invited to lecture on HoLEP in the UK and abroad and has convened annual HoLEP courses at CUH since 2005. He has demonstrated live laser prostate surgery (including the world’s first thulium laser enucleation of the prostate) at more than 30 conferences throughout the world. He also has experience with other BPH procedures including laser vaporisation, urolift, rezum and aquablation.

Tev was the founding President of the UK Holmium User Group (HUG). He designed and implemented the national HUG Training Programme for HoLEP (a model which is now used internationally),  and has mentored many surgeons in HoLEP.

Tev has been involved in HoLEP research from its earliest days, and has published and presented widely on the subject.